The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
CarMax, Inc.
KMX · the NYSE · USD · Market cap $7.3B · 27,796 employees
CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles and related products in the United States.
FAIL · Does not pass the screenPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price50.01 USD at the 19 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 19 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 2.26)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $59.52 to $99.21, base estimate $70.68 (screen dated 2026-11-19).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 2.26, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
CarMax, Inc. holds its Markup at $50.01. The statistical read favours the sellers, held for 68 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 68 days |
| Price at the screen | $50.01 |
| Valuation | 24.40 trailing · 14.27 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.23 |
Five Screens: KMX's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 70.33% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 1.24% | Below 49% | Pass |
| Revenue purity | 7.20% | Below 5% | Fail |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
CarMax,'s business is in a permissible area, but its interest-bearing debt is about 70% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KMX's ethical verdict changes
Today KMX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 29% discount to our $70.68 fair value, 17.70% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 29.2% discount to the base estimate.
Third-party analyst targets: 13 covering, consensus Hold. The average target sits +24% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $70.68, with a range of $59.52 to $99.21, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsUsed Car Chain Priced Beyond Its Reach
Picture a shopper haggling over a used car only to find the sticker already higher than any independent valuation. CarMax sits in that spot today. Revenue edges up just 6 percent while net margins scrape 1 percent and return on equity limps along at 4 percent. The shares trade at 18.9 times forward earnings, above our fair value of 55.87 dollars against a 57.33 dollar price, leaving no margin of safety and an explicit none rating from our screen.
Thirteen analysts already signal the same caution with a hold consensus and a 45 dollar median target. The ethical screen clears the business, yet the operating numbers do not support paying a premium. Low returns and thin margins leave little room for error in a market that can shift quickly.
Auto retail remains cyclical and exposed to interest rates, consumer confidence and used vehicle supply. A low multiple would normally raise eyebrows about peak earnings, but here the multiple is not low and the earnings power looks modest. The gap between price and both our value and the street target is the clearest signal to stay clear. Analysis, not advice.
| Forward P/E | 14.3xfairly priced for its growth rate |
| Trailing P/E | 24.4xa premium valuation |
| EPS, trailing | 2.11 |
| EPS, forward | 3.61 |
| Revenue growth | +17.7%steady growth |
| Profit margin | 1.0%barely profitable |
| Return on equity | 4.7%a modest return on shareholder capital |
| FCF yield | 8.65% |
| Debt to equity | 2.87heavy leverage: higher risk if revenue softens |
| Current ratio | 2.33comfortably covers its short-term bills |
| Beta | 1.23moves a little more than the market |
| Short interest, float | 0.08% |
| 52-week range | 30.69 - 65.28 |
| Market cap | $7.3B |
| Employees | 27,796 |
KMX-specific watchpoints · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter. Since the last review it entered the Titan Ethical 500; its composite score rose. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it hold, with a mean price target of $42. Insiders have been net buyers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- What Would Cooling Used-Car Demand Do To Carvana Stock? Yahoo Finance · 7d ago
- Should Value Investors Buy CarMax (KMX) Stock? Yahoo Finance · 7d ago
- Why Is Carvana (CVNA) Getting Attention Today? Yahoo Finance · 7d ago
- Can Carvana Stock Fall 40%? Yahoo Finance · 9d ago
- Averting Proxy Wars: 5 Companies Opting for Activist Investor Settlements Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Chawla Sona | Dir | Purchase | 2,000 | $10 |
| 2026-06-25 | Shinder Marcella | Dir | Purchase | 574 | $2 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-19 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-19 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-19 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-19 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-19 | Gil Cisneros | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $39.08 | +24.2% | · | $1,242 | +24.2% |
| 2 months | $46.72 | +3.9% | · | $1,039 | +3.9% |
| 3 months | $41.00 | +18.4% | · | $1,184 | +18.4% |
| 6 months | $41.65 | +16.5% | · | $1,165 | +16.5% |
| 1 year | $68.49 | -29.2% | · | $709 | -29.2% |
| 2 years | $68.47 | -29.1% | · | $709 | -29.1% |
| 3 years | $78.81 | -38.4% | · | $616 | -38.4% |
| 5 years | $116.85 | -58.5% | · | $415 | -58.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever KMX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.